{
    "Trade/Device Name(s)": [
        "Quest Diagnostics Methamphetamine Micro-Plate EIA"
    ],
    "Submitter Information": "Quest Diagnostics, Inc.",
    "510(k) Number": "K080381",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAF"
    ],
    "Summary Letter Date": "June 13, 2008",
    "Summary Letter Received Date": "June 17, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Methamphetamine Micro-Plate EIA"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methamphetamine"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "Orasure Oral Specimen Collection Device"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Competitive enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Quest Diagnostics Methamphetamine Micro-Plate EIA for qualitative detection of methamphetamine in oral fluid using EIA technology",
    "Indications for Use Summary": "Intended for qualitative screening of methamphetamine in oral fluid collected with the Orasure Oral Specimen Collection Device; provides preliminary results at 40 ng/ml cutoff, requiring confirmatory analysis for positive results",
    "fda_folder": "Toxicology"
}